QualityStocks
  The QualityStocks Daily Newsletter for Friday October 30th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

Standout Stocks (BLVI)

2.

OTC Picks (EGYF)

3.

Penny Stock Chaser (RGTX)


The QualityStocks Daily

Black Hawk Exploration Inc. (BHWX)

This week, Stock Preacher, Street Authority Financial, The Stock Advisors, Schaeffer's, StockHideout.com, Small Cap Network, Street Insider, Investor Soup, and Market FN reported on Black Hawk Exploration Inc. (BHWX).  MicroCap Gems, Investment House, The Best Newsletters, Another Winning Trade, Investopedia.com, Investors Alley, Daily Profit, Nathaniel Hayes did earlier this month, Coattail Investor, Oxbury News Bulletin, The Online Investor did previously, and we highlight the Company as "One to Watch" next week, here at the QualityStocks Daily Newsletter.

Black Hawk Exploration Inc. is a diversified metals and energy exploration company. Their current focus is on lithium exploration through their wholly owned subsidiary Blue Lithium. Black Hawk holds mineral rights to 1,120 acres in the lithium-rich Clayton Valley in Nevada. Clayton Valley is the home of the largest lithium brine production facility in the U.S. The Company is focusing on the acquisition, exploration, and development of highly-prospective North American lithium properties. Black Hawk Exploration Inc. has their headquarters in Fox Island, Washington and they trade on the OTC Bulletin Board.

This week, Black Hawk Exploration, Inc.’s management team, headed by Kevin M. Murphy, announced to their Black Hawk shareholders, friends, and the market a recap of their last quarter and significant milestones. In early August, Black Hawk launched a diversified energy and metals exploration program. The focus was on identifying and exploring strategic high value properties and developing new prospective projects globally. On August 11, the Company formed Blue Lithium Energy (Blue Lithium), a wholly owned Nevada subsidiary.

Black Hawk announced in a Press Release on September 28th, 2009 that they had officially launched a “Diversified Energy and Metals Exploration Program” through their subsidiary Blue Lithium. On September 30th, 2009, Black Hawk announced their Clayton Valley, Nevada acquisition. On October 19th, 2009, Black Hawk announced that they entered into an equity financing agreement for up to $1,000,000 from private investors.

The Company’s Clayton Valley claims and the worldwide demand for their potential lithium production is helping them secure investment. The signing of the equity financing agreement will allow the Company to fund the implementation of their operations and acquisitions strategy. They stated that the first priority of Blue Lithium would be their exploration program. Black Hawk Exploration Inc.’s corporate commitment is to an aggressive program of value-added property acquisition, project generation, asset diversity, and Shareholder value building.

We have our eye on Black Hawk Exploration Inc. (BHWX), and we're tracking them on our radar screens as "One to Watch" next week, here at the QualityStocks Daily Newsletter.

Black Hawk Exploration Inc. (BHWX) closed Friday's trading session at $0.80 down 26.94 percent. Volume was 1,827,694.

Artificial Life Inc. (ALIF)


Penny Invest and Stock Egg.com reported this week on Artificial Life Inc. (ALIF), HotOTC.com, Stock Guru, and Standout Stocks reported earlier and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTCBB, Artificial Life Inc. is a leading full service provider of award-winning mobile technology, mobile participation TV, games, and applications. Founded in 1994, Artificial Life Inc. went public in 1998. Current CEO, Eberhard Schoneburg, founded the Company in Boston. The Company is a pioneer in broadband mobile technology and the world's first full-service broadband mobile content and technology provider. Headquartered in Los Angeles, California, the Company has their production center in Hong Kong. They also have additional offices in Berlin, Germany, and a sales office in Tokyo, Japan.

Artificial Life provides mobile broadband 3G technology, mobile participation TV, mobile gaming, content, and mobile business applications. They also provide mobile advertisement and product placements and mobile aggregation and distribution.  Artificial Life provides 2D and 3D multi- and single player rich-media applications for 3G, 3.5G/HSDPA and 4G network-enabled mobile phones. The Company has received recognition internationally for outstanding content quality and technology.

The Company announced in 2008 that their mobile development tool MobileBooster™ now extends its support to the iPhone® and iPod® touch platforms. Created by Artificial Life for mobile 2G/3G applications and games, MobileBooster™ is a development tool and platform that facilitates the mobile rollout process and enhances business effectiveness. The extended support to the iPhone® and iPod® touch platform adds value to this tool. The Company is also using the Mobile Booster™ for all their internal iPhone® product developments.

The Company also offers mobile games mainly for broadband networks and mobile phones. Their mobile game product line includes Amateur Surgeon, Klitschko Boxing, Leo Messi-GOAL, Borussia Dortmund, V-boy, V-girl, and many more offerings. Artificial Life Inc. also provides mobile software packages, including MoPA-TV 3.0. This is mobile controlled interactive television shows and formats. They also offer Mobile Diab mobile business applications.

The Company also offers SmartEngine Mobile Platform/SEMP, a mobile technology platform for 2G and 3G phones, and mobile devices. In addition, they offer interactive in-game product placements in 2D and 3D, and individually sponsored and custom-developed mobile games. These are for advertising agencies, media companies, and global brands. Artificial Life operates a mobile portal site called botme.com. This site sells different products to end users. The Company also provides consulting, and custom specific project and product development services, and support for the creation and maintenance of mobile products.

On Monday of this week, Artificial Life, Inc. and 3M Company announced the signing of a securities purchase agreement. Under the Purchase Agreement, Artificial Life, Inc. sold to 3M 6,447,491 shares of their common stock at a price of $1.00 per share, for an aggregate consideration of $6,447,491. 3M and Artificial Life have also entered into an alliance agreement outlining the parties' intent to collaborate in the coming years in projects related to the research and development of new mobile device products and technology. The Alliance Agreement also provides that 3M and Artificial Life plan to cooperate in connection with the marketing of certain of Artificial Life's existing and new products.

Artificial Life Inc. (ALIF.OB) closed Friday's session at $1.28 up 14.33 percent. Volume was 617,501.

Genta Incorporated (GETA)

Stock Rich, HotOTC.com, Cool Penny Stocks, Hyper Growth Stock, Standout Stocks, Penny Invest, and StockEgg.com reported recently on Genta Incorporated (GETA), Penny Performers, and OTC Picks did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in Berkeley Heights, New Jersey, Genta Incorporated is a biopharmaceutical company with a diversified product portfolio. The Company focuses on delivering innovative products for the treatment of patients with cancer. Two major programs are the foundation of their research platform. These programs are DNA/RNA-based Medicines and Small Molecules. Genta Incorporated is an OTCBB-traded company.

The lead compound from Genta Incorporated's DNA/RNA Medicines program is Genasense® (oblimersen sodium) Injection. Genasense is in development as an agent that may enhance the effectiveness of current anticancer therapy. The leading drug in Genta's Small Molecule program is Ganite® (gallium nitrate injection). Genta is exclusively marketing this drug in the United States for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration.

Genta has developed G4544, an oral formulation of the active ingredient in Ganite.  G4544 has recently entered clinical trials as a potential treatment for diseases associated with accelerated bone loss.  The Company is also developing tesetaxel, a novel, orally absorbed, semi-synthetic taxane. It is in the same class of drugs as paclitaxel and docetaxel. Ganite and Genasense are available on a "named-patient" basis in countries outside the U.S.

Genta has a broad portfolio of proprietary products in various stages of clinical development. The Company's lead compound, Genasense® (oblimersen sodium) Injection, has undergone study in over 2300 patients with a wide variety of tumor types. The Company is leveraging their clinical oncology research expertise through expanding and diversifying their R&D pipeline.

Yesterday, Genta Incorporated announced top-line results from AGENDA, their Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy. AGENDA uses a biomarker to define patients who might maximally benefit from treatment. This is as defined in a prior randomized trial.

AGENDA did not show a statistically significant benefit for its co-primary endpoint of progression-free survival. Secondary endpoints of overall response rate and disease control rate also did not show a statistically significant benefit. The observed differences in progression-free survival, overall response, disease control, and durable response all numerically favored the group that received Genasense®. Overall survival – the other co-primary endpoint in AGENDA – is too early to evaluate, as prospectively specified.

Quantitative details of the announced results will be presented at the international conference, "Molecular Targets and Cancer Therapeutics", that will be held November 15-19, 2009, in Boston, Massachusetts. The AGENDA results will be featured in an oral session on Monday November 15, 2009 at 5:00 PM ET.

"At this time, we cannot predict whether more mature data will reveal a benefit in either overall survival or durable response," said Dr. Raymond P. Warrell., Jr., Genta's Chief Executive Officer. "However, the immediate failure to confirm a significant improvement in progression-free survival will preclude our submission of a regulatory application this year. Management and the Board are currently assessing the impact of these data on the Company's strategic direction."

Genta Incorporated (GETA) closed Friday's trading session at $0.2240 up 14.87 percent. Volume was 15,442,155.

Helix Wind, Corp. (HLXW)

This week, Bellwether Report reported on Helix Wind, Corp. (HLXW), and we highlight the Company too, here at the QualityStocks Daily Newsletter.

Incorporated in 2006, Helix Wind, Corp. engages in the small wind turbine alternative energy business. The Company offers a distributed power technology platform designed to produce electric energy from the wind. Helix Wind has primarily engaged in the research and development of their proprietary products. The Company engages in the design, manufacturing, and sale of small wind vertical axis turbines designed to generate 300W, 1kW, 2.0kW, 2.5kW, 4.5kW, 10kW, and 50kW of clean, renewable electricity. Trading on the OTCBB, Helix Wind, Corp. has their headquarters in San Diego, California.

Helix Wind, Corp. serves residential, commercial, governmental, educational, industrial, and agricultural sectors. The Company also serves developers, architects, and engineers. Helix Wind markets their products in Argentina, Uruguay, Paraguay, Chile, Brazil, Aruba, and the Antilles.

On October 6, 2009, Helix Wind Corp. reported that in an independent field test, their model S594 small wind turbine installed since March at a test site owned by PFG Green Energy is producing energy output within 90 percent of the Company's predicted performance. PFG Green is a Helix distributor near Cedar Falls, Iowa.

"The small-wind industry has grappled with the problem of grossly overstated output claims, this test demonstrates that Helix Wind turbines will produce what we say they will," said Helix Wind CEO Ian Gardner. "What's more, innovations such as our Wind Turbine Monitoring System (WTMS) give the customer continuous, real-time feedback on system performance, underscoring the company's commitment to transparency and accountability."

On Tuesday, Helix Wind Corp. reported that their S594 wind turbine installation in Dutch Harbor, Alaska, performed well during a major storm. It withstood winds in excess of 80 mph, according to its owners, Joshua Williams and Lilia Howard of Dutch Harbor. The S594 turbine underwent installation in Dutch Harbor in June. Dutch Harbor’s weather is considered among the worst in the world, with approximately 250 rain days annually.

Today, Helix Wind, Corp. (HLXW) closed trading at $3.03 up 1.00 percent. Volume was 105,647.

iTech Medical, Inc. (IMSU)

Penny Stock Chaser reported this month on iTech Medical, Inc. (IMSU), Microcap Money, Triple Crown Stocks, Investor Voice did previously, and we highlight the Company, here at the QualityStocks Daily Newsletter.

iTech Medical, Inc. is an information technology company that trades on the OTC Bulletin Board. The Company engages in the research and commercial development of healthcare information systems and technologies. They have developed a proprietary platform called Muscle Pattern Recognition (MPR). iTech Medical, Inc. has their corporate headquarters in Huntington Beach, California.

The Company's proprietary Muscle Pattern Recognition (MPR) platform is a unique clinical tool for the analysis of muscle function. MPR is a patented clinical tool that analyzes patterns of muscle recruitment. It provides detailed physiological information on muscle function. This information can assist in the diagnosis and treatment of back and neck injuries and illness. MPR has received positive peer review in three published technical papers.

The results of an MPR test are presented in a comprehensive report. The report provides detailed information on muscle function incorporating site, nature, and severity of dysfunction. Clinical trials of the MPR System are currently underway. The goal of the studies is to demonstrate that the MPR System can differentiate normal from abnormal biomechanical function in a population suffering from neck or back pain.

Earlier this month, iTech Medical, Inc. announced plans to expand their clinical and commercial programs for MPR into the European Union (EU). They signed a Letter of Intent with Sportplein Eindhoven to participate in the Company's clinical and commercial programs relating to the introduction of the MPR technology in the EU. Sportplein Eindhoven is a Dutch healthcare practice specializing in back pain, physical therapy, and sports injuries.

On October 12, 2009, iTech Medical, Inc. highlighted their proprietary information technology platform, Muscle Pattern Recognition (MPR), at BioContact Quebec 2009. BioContact Quebec 2009 featured over 140 companies from Canada, the United States, Asia, and Europe. The event had presentations in key sectors of activities (diagnostics, therapeutics and services) and disciplines ranging from cancer and medical technologies to metabolism and virology.  iTech Medical, Inc.'s presentation was well received by both the conference attendees from the biomedical industry, as well as the business development and investment communities.

iTech Medical, Inc. (IMSU) closed Friday's session at $0.25 up 25.00 percent. Volume was 32,498.

Power3 Medical Products Inc. (PWRM)


PennyOmega.com, DrStockPick.com, and Momentum Traders reported yesterday on Power3 Medical Products Inc. (PWRM), OTC Picks and OTC Select did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the OTC Bulletin Board, Power3 Medical Products Inc. engages in the early detection, monitoring, and targeting of diseases through the analysis of proteins. Headquartered in The Woodlands, Texas, they work in areas such as cancer, and neurodegenerative diseases such as Parkinson's and Alzheimer's. Their original focus was on research and development but they have moved now into the commercialization of their technologies and products. Founded in 1992, the Company began as a medical device enterprise.

Power3 Medical Products Inc. purchased ProteEx of The Woodlands, Texas, in 2004. Founded in 2000, ProteEx was a company with much protein expertise. Power3 now operates a CLIA (Clinical Laboratory Improvement Amendment) certified proteomics lab at their headquarters in The Woodlands. Proteomics is the science of protein interactions within living cells. Power3's patent-pending technologies find use in developing screening and diagnostic tests for the early detection and prognosis of disease. They also find use in helping identify protein biomarkers and drug targets.

The Company targets their diagnostic tests toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro®). NuroPro® is a series of three separate and distinct blood serum tests designed to diagnose Alzheimer's, Parkinson's or Lou Gehrig's disease (ALS) in individuals. The test is based on proteomic technology.

Power3 recently signed their first distribution agreement to provide their blood serum diagnostic for breast cancer, BC-SeraPro™, in twelve Middle Eastern countries. In August, Power3 Medical Products, Inc. announced that they made significant advances in the technology for their BC-SeraPro serum protein based blood test for diagnosis of early stage breast cancer. This is as disclosed in filings of three pending U.S. utility patent applications.

On September 2, 2009, Transgenomic, Inc. and Power3 Medical Products, Inc. announced the on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease."  This is in the scientific journal Biochemical and Biophysical Research Communications. The study demonstrates the usefulness of a protein biomarker panel to distinguish Parkinson's disease (PD) patients from age-matched normal controls independent of the severity of symptoms, using clinical blood serum samples.

The analytic technology forms the basis for the NuroPro®PD test for PD being commercialized by Transgenomic. This is as per a licensing/collaboration agreement with Power3 Medical signed early this year. The publication of the peer-reviewed article is a significant validation milestone in the ongoing clinical development of the NuroProPD diagnostic assay.

Power3 Medical Products Inc. (PWRM) closed Friday's trading session at $0.0790 up 50.48 percent. Volume was 7,670,951.

Sea 2 Sky Corporation (SSKY)

Breakout Pennystocks, Lebed.biz, Wall Street Grand, Shazamstocks.com, and SmallCap Voice reported earlier on Sea 2 Sky Corporation (SSKY), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Headquartered in Ferndale, Washington, Sea 2 Sky Corporation is an indigenous renewable bio-energy company. Their primary focus is to deliver alternative energy solutions to Fortune 1000 companies, governmental agencies, and countries worldwide. Founded in 2005, Sea 2 Sky currently engages in the manufacturing and fulfillment process of wood pellets to Western European countries as a fuel and energy alternative. They are an OTCBB-traded company.

Sea 2 Sky Corporation is able to secure a major portion of the largest concentration of biomass material in North America. The Company is considered a "Special Category Minority Backed Business." This enables them to compete effectively in a growing market. Contracts for long-term supply of pellet biomass allow Sea 2 Sky to provide market security and standards to various markets.  The Company can also access carbon credits and they have the ability to market and present new biomass products into the U.S. market.

Sea 2 Sky is positioning to become one of the major players in the wood pellet business. They will be active in North, Central and South America, as well as South East Asia.  The Company accesses supply areas of biomass located in secure politically stable countries.  They then bring that product, by way of pellets, to the marketplace. The Company looks to partner with various indigenous groups who desire to bring their natural resources to market in an environmentally wise fashion.  The Company provides theses groups with access to living wage jobs to produce product that is needed globally.

In September, Sea 2 Sky Corporation updated their shareholders concerning their Biomass and Torrefaction implementation. Torrefaction is a scientifically proven method for improving the properties of Biomass as a fuel. The result of Torrefied pellets is the formation of a solid product that retains approximately 70 percent of its initial weight and 90 percent of the original energy content. Sea 2 Sky plans to apply this technology to increase the energy output in Biomass products and to provide a coal like product with significant environmental advantages. Sea 2 Sky plans to market the Torrefied Biomass to existing coal factories to be co-fired in a pulverized coal boiler.

Sea 2 Sky Corporation (SSKY) closed Friday's session at $0.0890 on no volume.

Technest Holdings Inc. (TCNH)

Today we are highlighting Technest Holdings Inc. (TCNH), here at the QualityStocks Daily Newsletter.

Technest Holdings, Inc. is a provider of advanced remote sensor systems, intelligent surveillance, and advanced 3D imaging technology solutions. These are to the defense, homeland security, and healthcare marketplaces. Their clients include a broad spectrum of government, commercial, medical, and dental organizations. Technest Holdings Inc. trades on the OTC Bulletin Board and they have their corporate headquarters in Bethesda, Maryland.

The Company's commitment is to setting next-generation imaging standards. They work to do this through the provision of innovative emerging technologies. Technest focuses, through strategic development, on the creation of dual-use technology and products.

Technest offers advanced imaging products and complete solutions for three-dimensional (3D) Imaging and Display, Intelligent Surveillance, and 3D Facial Recognition. Their products leverage many core technology platforms. These include 3D Imaging Technology Platforms. This involves 3D capture using patented Rainbow 3D technology; 3D processing, data manipulation, and advanced modeling; and 3D display in volumetric space.

They also have their Intelligent Surveillance Technology Platforms. These involve 360-degree video acquisition using mirror, lens, and array configurations, as well as 2D video detection, tracking, recognition, and enhancement software. They also have 3D Facial Recognition Technology Platforms, with 3D facial image acquisition and recognition algorithms and software. In addition, Technest has General Technology Platforms, with high-speed imaging processing hardware and embedded algorithms.

For Intelligent Surveillance Products the Company's OmniEye 360-degree family of surveillance systems represents one of the video surveillance market's leading and most flexible wide-area sensor capabilities. They have many configurations available to meet different needs for commercial, government, and military customers. Their Smart Optical Sensor (SOS) for intelligent surveillance enables remote surveillance by bringing USB 2.0, Ethernet, or wireless interfaces to any sensor.

Technest's Smart SuiteT of intelligent algorithms enables sensor existing systems to perform advanced tasks. These include motion detection, image enhancement, and tracking. Their OmniEye Viewer software suite provides an advanced set of tools for users to control cameras and algorithms.

Technest Holdings Inc. (TCNH) closed Friday at $0.4010 up 54.23 percent. Volume was 113,026.

The QualityStocks Company Corner

Newport Digital Tech, Inc. (NPDT)
Muscle Flex Inc. (MFLI)
Omnicity Corp. (OMCY)
DataCall Technologies, Inc. (DCLT)

Consorteum Hldgs, Inc. (CSRH) BLOG
Omnicity Corp. (OMCY) BLOG
Neptune Tech. & Bioresources BLOG
Carbonics Capital Corp. (CICS) BLOG

Newport Digital Technologies, Inc. (NPDT)

The QualityStocks Daily Newsletter would like to spotlight Newport Digital Technologies, Inc. (NPDT). Today, Newport Digital Technologies, Inc. closed trading at $0.0322, which was up 7.33 percent. Their volume today was 1,326,072 shares.

Newport Digital Technologies, Inc. announced that they have agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards.

Newport Digital Technologies, Inc. also announced that it has implemented the licensing agreement with Microsoft Corp. (NASDAQ: MSFT) to develop applications for its Windows Mobile platform. The Company has also progressed with their distribution agreement previously announced with Ingram Micro, Inc. (NYSE: IM), which will serve as its initial primary sales channel partner.

Newport Digital Technologies, Inc. (NPDT) offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900 engineers and scientists, these R&D powerhouses have developed cutting edge capabilities in fields such as Information Communications Technology (ICT), electronics, and nanotechnology.

Newport’s management team has accumulated a wealth of knowledge and experience within the technology industry as well as the corporate world. Maintaining a strong track record of delivering results to investors and customers, the team retains over two centuries of combined experience. Leveraging each team member’s area of expertise, Newport has established a solid foundation to penetrate emerging technology markets.Disclaimer

Newport Digital Technologies, Inc. Message Board

Newport Digital Technologies, Inc. Blog

Newport Digital Technologies, Inc. News:

Newport Digital Technologies to Implement Microsoft Licensing Agreement; Prepares to Launch First Ruggedized RFID Reader with the Windows Mobile Operating System

Newport Digital Technologies, Inc. (NPDT) to be Featured in Small Cap Stock Newsletter QualityStocks Daily

The New Age of Partnerships

Muscle Flex Inc. (MFLI)

The QualityStocks Daily Newsletter would like to spotlight Muscle Flex Inc. (MFLI). Today, Muscle Flex Inc. closed trading at $0.022. Their volume today was 1,627,963 shares.

Muscle Flex Inc. announced that they will soon be ready to release their Muscle Flex VATA Brasil™ Sports and Active Wear Ecommerce site as the finishing touches on the first-generation site are completed.

Muscle Flex Inc. (MFLI) is a leading edge fitness, health and lifestyle company focused on developing exciting brands and new products to market using direct response TV advertising and infomercials as well as cutting edge brand and image marketing. The company has designed all its products with the average person's lifestyle in mind.

Muscle Flex Inc. VATA Brasil sports and active wear collection is an ultra comfortable active wear line that utilizes superior moisture control fabric. The VATA Brasil OneFit fabric is an amazing innovation in sporting wear apparel, offering the advantages of being lightweight, highly elastic, and having four times the filaments than regular fabric.

The company’s newest product, The BUDDY Tablet Caddy™, is a personal, compact and portable tablet caddy with three individual compartments and a digital timer to remind users when it’s time to take vitamins or prescriptions. The pharmacist approved tablet caddy ensures the maximum effectiveness of all medications and supplements.

Founder and CEO Danny Alex leads the company with nearly three decades of experience in the health, fitness and athletic lifestyle. Since a young age, regular exercising and maintaining a healthy lifestyle has been a key part of Danny’s life. Today, it is his passion to help others get excited about themselves through fitness and healthy living. Disclaimer

Muscle Flex Inc. Blog

Muscle Flex Inc. News:

Muscle Flex Readies to Release Its Muscle Flex VATA Brasil Ecommerce Site and Has Expanded the Collection From 25 to 55 Pieces

Muscle Flex Eyes International Distribution for The BUDDY Tablet Caddy and The Beagle StepFit Pedometer

Muscle Flex Chooses Moulton Logistics for Its Fulfillment, Customer Service Call Center, Inventory & Database Management

Omnicity Corp. (OMCY)

Omnicity Corp. issued a formal corporate update summarizing the milestones achieved and the status of Omnicity's aggressive fiscal 2010 growth plan through acquisitions and organic growth.

The QualityStocks Daily Newsletter would like to spotlight Omnicity Corp. (OMCY) Today, Omnicity Corp. closed trading at $0.365. Their volume today was 64,712 shares.

Omnicity Corp. (OMCY) provides broadband access, including advanced services of voice, video and data, in un-served and underserved small and rural markets. The company aims to be the premier consolidator of rural market broadband nationwide. Leveraging management expertise, Omnicity’s strategy is to provide a total broadband solution and continue rapid growth through acquisitions, organic growth and partnerships with Rural Electric Municipal Cooperatives and Rural Telephone Companies.

The company’s target markets are locations better suited to wireless transmissions than traditional hard-wire operators. It has been estimated that at least 40 million rural and small market homes, businesses, government agencies and schools have inadequate high-speed Internet service, representing a large growth opportunity.
Building a nationwide wireless network, Omnicity will be able to deliver high-speed Internet access to rural subscrib­ers more cost-effectively than traditional cable or fiber optic models since hard-wire systems are gener­ally much more expensive to build than wireless networks. Reduced network development costs means lower infrastructure costs per subscriber for wireless operators as compared to comparably-sized traditional hardwire fiber-optic systems.

Omnicity is led by an experienced broadband operations team with extensive wireless broadband/ISP expertise as well as the capability to consolidate large numbers of businesses through a strategic roll-up strategy. Over the next five years, the company projects a growing customer base of 170,000 subscribers, increasing margins and growing revenues of nearly $87 million. Disclaimer

Omnicity Corp. Blog

Omnicity Corp. News:

OMNICITY ISSUES CORPORATE UPDATE

Omnicity Announces Record Revenue and Significant Subscriber Increase for Q4 09

Omnicity Approved for Electronic Trading

DataCall Technologies, Inc. (DCLT)

The QualityStocks Daily Newsletter would like to spotlight DataCall Technologies, Inc. (DCLT) Today, DataCall Technologies, Inc. closed trading at $0.017, which was up 6.25 percent. Their volume today was 60,000 shares.

DataCall Technologies, Inc. (DCLT) was founded with the vision to develop and deliver the first wirelessly fed information feed containing sports scores and sports news. As the company enhanced their product, they began offering additional content sources such as financial news, national and world news, weather, traffic, horoscope, trivia and more. During this time of development and growth, digital signage began gaining recognition as an explosive and lucrative industry.

Over the past few years, DataCall has shown impressive growth in its customer base and gross revenues. By establishing early strategies and corporate partnerships, the company has been able to penetrate nearly all digital signage venues. DataCall’s feeds are now delivered to a broad range of locales including: medical centers, banks, hotels, resorts, schools, gas stations, universities, restaurants, bill boards, and Public Broadcast Stations.

It has been forecasted that North American digital signage spending will total $1.6 billion in 2009 (up 24% from 2008) and will continue to grow to a projected $2.6 billion by 2011. The increasing affordability of displays and other essential equipment, ability to update feeds in real-time, and the capability to send targeted messages during various times of the day continue to fuel the growth of this quickly emerging industry.

Data Call is committed to expanding its product offerings and plans to move into other vertical markets within its targeted industry. Moving forward, Data Call will be focusing on growing its subscriber base, while maintaining aggressive expenditure management. The company is also in negotiations to acquire a likeminded company, which will enable a stronger penetration in the digital signage and IT networks technology industries. Disclaimer

DataCall Technologies, Inc. Blog

DataCall Technologies, Inc. News:

Data Call Technologies Extends International Distribution Network to Jamaica, Expands US Network to 37 States

QualityStocks Features Data Call Technologies, Inc. in Exclusive Interview

Data Call Technologies Now Offers Comprehensive Weather Coverage to 215 Countries

Consorteum Holdings, Inc. (CSRH.OB) – The Right Payment Solutions Partner

Consorteum Holdings Inc. provides financial services, payment and transaction processing services to firms in both the public and private sector. The company’s business strategy is to build on their expertise within the payments and transaction industry in North America, Europe and elsewhere.

The company first identifies new business opportunities and technology trends for their clients and then they develop customized solutions for their clients to meet the challenges of the fast-changing global marketplace. Consorteum is especially focused on helping their clients in several areas including: to deliver unique products and services more effectively and efficiently, improve operational performance and therefore increase revenues in existing markets, and also to enter new markets.

What distinguishes Consorteum in the marketplace is their demonstrated capability to provide clients with the right solutions. The company’s extensive relationships within the payment and transaction industries along with other world-leading companies give them the ability to provide their clients with the best possible solutions.

Consorteum has secured a number of strategic relationships and lucrative long-term (3-4 year minimum) contracts. This allows the company to continue to grow right alongside their clients and to have a very positive outlook going forward. The company has revenue projection of over $4.8 million in 2009-10 and believes they will be cash flow positive by the end of the fourth quarter of 2009, with monthly revenues of approximately $150,000, and a monthly operating expenditure of under $100,000. In addition, Consorteum is currently negotiating contracts for 2010 and beyond, worth an additional $6 million plus in revenues.

The company has built its reputation with one goal – for their customers to look at them as partners, not just another technology provider.

Omnicity Corp. (OMCY.OB) Issues Corporate Update to Investor Community

Omnicity Corp., the Midwest’s largest and fastest growing fixed Wireless Internet Service Provider, yesterday updated the investment community with a formal corporate update summarizing the milestones achieved and the status of Omnicity’s aggressive fiscal 2010 growth plan through acquisitions and organic growth.

David Bradford, Chief Operating Officer of Omnicity, stated, “In the first 8 months, since completing our public listing, we proved our acquisition model works very well. We have completed five acquisitions and integrated them into Omnicity operations very smoothly. All these acquisitions were highly accretive, coming over with high operating margins, and some of them yielded high quality employees as well.”

Mr. Bradford continued, “We have a number of additional acquisitions in various stages of closure, with more to follow, and expect to close and integrate them with the same fine results. These acquisitions alone, combined with an aggressive set of sales and marketing campaigns, should put us well in excess of 11,000 subscribers and annualized running rate revenue of well over $5 million by the end of the next fiscal year.”

Omnicity’s plan of operations through its 2010 fiscal year includes:

  • completing further debt and equity offerings of $5,000,000 and building current ratio of 1.5:1 by December 31, 2009;
  • completing several acquisitions to double subscribers to over 11,000 and doubling revenue to $1,300,000 per quarter;
  • developing and expanding, through organic growth, the subscriber base through its sales and marketing program;
  • acquiring and transitioning into its operations assets of competing WISP operators and expanding its network into all of Midwest USA;
  • reaching operationally cash flow positive and building a liquidity floor under operations of $100,000 minimum by December 31, 2009;
  • continuing to partner with Rural Electric Membership Cooperatives “REMCs”, local and State governments, Rural Telcos and Original Equipment Manufacturers “OEMs” to efficiently and cost effectively expand our network across rural America;
  • developing and expanding service offerings to become a total broadband solution; and
  • completing a further staged equity offering of $10,000,000 by July 31, 2010 followed by an application to list on a senior stock exchange.

Neptune Technologies & Bioressources Inc. (NEPT) Awarded Method of Use Patent for Heart Disease

Neptune Technologies & Bioressources Inc. announced that the patent, “KRILL EXTRACTS FOR PREVENTION AND/OR TREATMENT OF CARDIOVASCULAR DISEASES,” was successfully issued in Europe, marking an integral achievement in eliminating competition of other entities focused on krill extract in the European cardiovascular market.

The issuance of the patent is expected to thwart unregulated marketing of krill oil and relative products.

“Recently, we observed players cheating on the market and misleading consumers by selling krill oil in Europe without any regulatory approval. We also noticed that they advertise unproven health benefits with their products as well as infringe on our patents. This was surprising until we realized who were involved. These situations will be addressed as required,” Henri Harland, CEO and president of Neptune stated in the press release.

The company also announced that the European Food Safety Authority (EFSA) signed the approval of Neptune Krill Oil as a Novel Food and PARNUTS for commercialization in the EU.

Dr. Tina Sampalis, chief scientific officer of Neptune, explained the details and benefit of the novel food designation.

“The placing in the EU market of novel food or novel food ingredients, which have not been authorized or notified within the framework of Regulation 258/97, will have as a consequence the immediate withdrawal of the non-compliant products from the EU market by the competent national authorities of the Member States by notification of the Commission through the Rapid Alert System for Food and Feed (RASFF). This is in addition to any other liabilities that can be deducted from the Member States’ national legislation. Moreover, violating Neptune’s rights by infringing on any of its patents by any players in the krill oil market is also considered a legal offence,” Dr. Sampalis stated in the press release.

Carbonics Capital Corp. (CICS.OB) Signs Agreement to Lease Montana Oilseed Plant

Today, Carbonics Capital Corp. announced that Great Plains Oil & Exploration, LLC will lease the company’s oilseed crush plant in Culbertson, Montana. Great Plains will use the facility in further development of their oilseed production program. The announcement follows the execution of an agreement between the companies.

Culbertson consists of oilseed handling, storage and processing infrastructure, including mechanical crush and vegetable oil refining equipment. It has over two million gallons of crude vegetable oil storage, over one million bushels of oilseed storage, and over four thousand tons of meal storage. Additional infrastructure includes a rail siding, truck and rail scales, and major U.S. highway frontage.

The lease presents a lucrative opportunity for Carbonics to expand its business enterprise. In 2008, Culbertson was unable to renew its working capital line of credit, and was therefore unable to complete its purchase of delivered oilseed inventory. After several months of difficult work, and the tremendous efforts of Montana and North Dakota regulatory officials, Carbonics reported its complete liquidation in October 2009. Presently, with this lease agreement, activity occurring at the facility is an effort to resume and revive operations.

Dr. Paul Miller, Carbonics’ president and CEO, stated, “Activity at Culbertson is very important right now. A completely shut facility is not an ideal situation and this lease keeps personnel on sight, augers conveying, and trucks rolling. We are delighted that Great Plains shares our belief in the value of Culbertson, the region and the opportunities for oilseed production and processing.”

Sam Huttenbauer, CEO of Great Plains Oil, added, “We are delighted to be able to add the Culbertson facility to our growing list of camelina storage and processing facilities. This will provide an important central hub for our camelina growers in eastern Montana and western North Dakota.”

 


Sponsors of the Day

The QualityStocks Public Company Sponsor News

QualityStocks


 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336